Terazosin - 60505-0115-1 - (Terazosin)

Alphabetical Index


Drug Information of Terazosin

Product NDC: 60505-0115
Proprietary Name: Terazosin
Non Proprietary Name: Terazosin
Active Ingredient(s): 1    mg/1 & nbsp;   Terazosin
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Terazosin

Product NDC: 60505-0115
Labeler Name: Apotex Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075498
Marketing Category: ANDA
Start Marketing Date: 20010412

Package Information of Terazosin

Package NDC: 60505-0115-1
Package Description: 1000 CAPSULE in 1 BOTTLE (60505-0115-1)

NDC Information of Terazosin

NDC Code 60505-0115-1
Proprietary Name Terazosin
Package Description 1000 CAPSULE in 1 BOTTLE (60505-0115-1)
Product NDC 60505-0115
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Terazosin
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20010412
Marketing Category Name ANDA
Labeler Name Apotex Corp.
Substance Name TERAZOSIN HYDROCHLORIDE
Strength Number 1
Strength Unit mg/1
Pharmaceutical Classes Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

Complete Information of Terazosin


General Information